Drug susceptibility testing (DST)
Drug susceptibility testing (DST) is a laboratory procedure used to determine the effectiveness of specific antimicrobial agents against pathogens, particularly bacteria and fungi. This testing is crucial in guiding the appropriate treatment for infections and combating antibiotic resistance.
DST can be conducted for various purposes, including:
1. Identifying Effective Treatment:
By determining which drugs a pathogen is sensitive or resistant to,
healthcare providers can choose the most effective treatment regimen.
2. Monitoring Resistance Trends:
TDST helps in tracking the emergence and spread of antimicrobial resistance, which is essential for public health
surveillance and developing strategies to counteract resistance.
3. Ensuring Quality Control:
DST is used in clinical laboratories to ensure the reliability and accuracy of
antimicrobial agents and testing procedures.
Common methods of DST include:
Broth Dilution:
Involves exposing the pathogen to varying concentrations of the antimicrobial agent in a liquid medium to determine the minimum inhibitory
concentration (MIC) that inhibits the growth of the organism.
Agar Dilution:
Similar to broth dilution, but performed on solid media (agar plates).
Disk Diffusion (Kirby-Bauer Test):
Disks impregnated with antibiotics are placed on an agar plate inoculated with the pathogen.
The zone of inhibition around each disk is measured to determine susceptibility.
Etest (Epsilometer Test):
Uses a strip impregnated with a gradient of the antibiotic. The point at which the
bacterial growth intersects the strip indicates the MIC.
Molecular Methods:
Techniques like polymerase chain reaction (PCR) to detect genetic markers associated with resistance.
Overall, DST is a vital tool in modern medicine, ensuring that infections are treated with the most effective and appropriate antimicrobial agents.